Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: A study in different clinical subgroups with and without extracutaneous cancer

American Journal of Dermatopathology

Volumn 29, Issue 4, 2007, Pages 351-358

  Cesinaro, Anna Maria ^a,c   Ubiali, Alessandro ^b   Sighinolfi, Pamela ^a   Trentini, Gian Paolo ^a   Gentili, Francesca ^b   Facchetti, Fabio ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Microsatellite instability; MMR proteins; Muir Torre syndrome; Sebaceous; Skin

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER; CANCER LOCALIZATION; COLON CANCER; DIGESTIVE SYSTEM CANCER; FACE CANCER; FEMALE; GENETIC DISORDER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; KIDNEY CANCER; LARYNX CANCER; LIP CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MUIR TORRE SYNDROME; NASOPHARYNX CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RECTUM CANCER; SEBACEOUS CARCINOMA; SEBACEOUS GLAND DISEASE; SKIN DEFECT; SKIN TUMOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASE PAIR MISMATCH; CHILD; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; FACIAL NEOPLASMS; FEMALE; GASTROINTESTINAL NEOPLASMS; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASMS, MULTIPLE PRIMARY; NUCLEAR PROTEINS; SEBACEOUS GLAND NEOPLASMS; SYNDROME; URINARY BLADDER NEOPLASMS;

EID: 34547702208     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e318057713c     Document Type: Article

References (30)

1. Muir EG, Yates-Bell AJ, Barlow KA. Multiple primary carcinomata of the colon, duodenum and larinx associated with keratoacanthomas of the face. Br J Surg. 1967;54:191-195.
2. Torre D. Multiple sebaceous tumors. Arch Dermatol. 1968;98:549-551.
3. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol. 1995;33:90-104.
4. Descalzi ME, Rosenthal S. Sebaceous adenomas and keratoacanthomas in a patient with malignant lymphoma. A new form of Torre-Muir Syndrome. Cutis. 1981;28:169-170.
5. Cohen PR. Muir-Torre syndrome in patients with hematological malignancies. Am J Hematol. 1992;40:64-65.
6. Kruse R, Ruzicka T. DNA mismatch repair and the significance of a sebaceous skin tumor for visceral cancer prevention. Trends Mol Med. 2004;10:136-141.
7. Honchel R, Halling KC, Schaid DJ, et al. Microsatellite instability in Muir-Torre sindrome. Cancer Res. 1994;54:1159-1163.
8. Kruse R, Rutten A, Lamberti C, et al. Muir-Torre phenotype has a frequency of DNA mismatch-repair gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet. 1998;63:63-70.
9. Mangold E, Pagenstecher C, Leister M, et al. A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet. 2004;41:567-572.
10. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-5257.
11. Marcus VA, Madlensky L, Gryfe R, et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol. 1999;23:1248-1255.
12. Lynch HT, Fusaro RM. The Muir-Torre syndrome in kindreds with hereditary nonpolyposis colorectal cancer (Lynch syndrome): a classic obligation in preventive medicine. J Am Acad Dermatol. 1999;41:797-799.
13. Mathiak M, Rutten A, Mangold E, et al. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations. Am J Surg Pathol. 2002;26:338-343.
14. Shia J, Ellis NA, Klimstra DS. The utility of immunohistochemical detection of DNA mismatch repair gene proteins. Virchows Arch. 2004;445:431-441.
15. Chapusot C, Martin L, Puig PL, et al. What is the best way to assess microsatellite instability status in colorectal cancers? Study on a population base of 462 colorectal cancers. Am J Surg Pathol. 2004;28:1553-1559.
16. Allen RC, Graves G, Budowle B, et al. Polimerase chain reaction amplification products separated on rehydratable polyacrilamide gels and stained with silver. Biotechniques. 1989;7:736-744.
17. Dietmaier W, Wallinger S, Bocker T, et al. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res. 1997;57:4749-4756.
18. Machin P, Catasus L, Pons C, et al. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome. J Cutan Pathol. 2002;29:415-420.
19. Entius MM, Keller JJ, Drillenburg P, et al. Microsatellite instability and expression of MLH-1 and MSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res. 2000;6:1784-1789.
20. Popnikolov NK, Gatalica Z, Colome-Grimmer MI, et al. Loss of mismatch repair proteins in sebaceous gland tumors. J Cutan Pathol. 2003;30:178-184.
21. Southey MC, Young M-A, Whitty J, et al. Molecular pathologic analysis enhances the diagnosis and management of Muir-Torre syndrome and gives insight into its underlying molecular pathogenesis. Am J Surg Pathol. 2001;25:936-941.
22. Ponti G, Ponz de Leon M, Losi L, et al. Different phenotypes in Muir-Torre syndrome. Clinical and biomolecular characterization in two Italian families. Br J Dermatol. 2005;152:1335-1338.
23. Ponti G, Ponz de Leon M. Muir-Torre syndrome. Lancet Oncol. 2005;6:980-987.
24. Lynch HT, Lynch JF. 25 years of HNPCC. Anticancer Res. 1994;14:1617-1624.
25. Weinstein A, Nouri K, Bassiri-Tehrani S, et al. Muir-Torre syndrome: a case of this uncommon entity. Int J Dermatol. 2006;45:311-313.
26. Graells J, Marcoval M, Badell A, et al. Muir-Torre syndrome in a patient with acquired immunodeficiency syndrome. Br J Dermatol. 1996;135:159-161.
27. Harwood CA, Swale VJ, Bataille VA, et al. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. J Invest Dermatol. 2001;116:246-253.
28. Kruse R, Rutten A, Schweiger N, et al. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias. J Invest Dermatol. 2003;120:858-864.
29. Scartozzi M, Bianchi F, Rosati S, et al. Mutations of hMLH1 and hMSH2 in patients with suspected Hereditary Nonpolyposis Colorectal Cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression. J Clin Oncol. 2002;20:1203-1208.
30. Hitchins M, Williams R, Cheong K, et al. MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterology. 2005;129:1392-1399.